2 research outputs found
Risk management and comparative effectiveness research: implications of the new collaborative FDA-CMS initiative
- Author
- AHRQ
- Baciu
- Blue Cross/Blue Shield. Technology Assessment Center
- Burrell & Company
- Chou
- Clancy
- DHHS Office of the Inspector General
- Federal Food and Drug Administration Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research
- Herdman
- Hobson
- Inglehart
- Norris
- Oxford Centre for Evidence-Based Medicine
- Pearson
- Sox
- U.S. Department of Health and Human Services
- US Preventive Services Task Force (USPTF)
- Publication venue
- 'Wiley'
- Publication date
- Field of study
The Big 3
- Author
- Ahnen
- American Cancer Society (ACS)
- American Cancer Society (ACS)
- American Cancer Society (ACS)
- American Cancer Society (ACS)
- American Cancer Society (ACS)
- American Cancer Society (ACS)
- American College of Radiology
- Beaber
- Beral
- Bertrand
- Carroll
- Chelbowski
- Cigler
- Compton
- Drukteinis
- Dunn
- Ellerhorn
- Erica Fischer-Cartlidge
- Ferraldeschi
- Finn
- Freer
- Friedewald
- Gianni
- Giuliano
- Grenon
- Hegarty
- Institute of Medicine National Research Council
- Jeanine Gordon
- Krop
- Kushi
- Lawson
- Lodewijk
- Maliska
- Manson
- Margaret Barton-Burke
- McIntyre
- Moran
- National Comprehensive Cancer Network
- Nelson
- Oeffinger
- Page
- Poon
- Rastogi
- Roe
- Siegel
- Small
- Surveillance Epidemiology, and End Results (SEER)
- Swain
- US Food and Drug Administration (FDA)
- US Food and Drug Administration (FDA)
- US Food and Drug Administration (FDA)
- US Preventive Services Task Force (USPTF)
- Wilkes
- Yardly
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study